<DOC>
	<DOC>NCT00310635</DOC>
	<brief_summary>Safety, Tolerability and Immunogenicity of Meningococcal C Conjugate Vaccine to Children 32 to 40 Months of Age</brief_summary>
	<brief_title>Safety, Tolerability and Immunogenicity of Meningococcal C Conjugate Vaccine to Children 32 to 40 Months of Age</brief_title>
	<detailed_description />
	<mesh_term>Meningococcal Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy children known hypersensitivity to any vaccine component significant acute or chronic infections requiring systemic antibiotic treatment or antiviral therapy within the past 14 days ascertained or suspected disease caused by N. meningitidis household contact with or intimate exposure to an individual with a positive culture of N. meningitidis serogroup C within the previous 60 days</criteria>
	<gender>All</gender>
	<minimum_age>32 Months</minimum_age>
	<maximum_age>40 Months</maximum_age>
	<verification_date>October 2006</verification_date>
	<keyword>Prevention of meningococcal infection</keyword>
</DOC>